Purchases and Sales Made in Q4 2023 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q4 2023. The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-117K- 11.22% |
$50.4K - $92.7K
|
928K
$566K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-150K- 4.23% |
$64.5K - $119K
|
3.4M
$2.07M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-211K- 32.35% |
$90.7K - $167K
|
441K
$269K
|
|
|
Feb 14, 2024
Q4 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-362K- 13.0% |
$156K - $286K
|
2.43M
$1.48M
|
|
|
Feb 14, 2024
Q4 2023
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-500K- 10.23% |
$215K - $395K
|
4.39M
$2.68M
|
|
|
Feb 13, 2024
Q4 2023
|
Mpm Asset Management LLC
Cambridge, MA |
SELL
|
- |
-732K- 11.64% |
$315K - $578K
|
5.56M
$3.39M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.09M- 85.82% |
$467K - $858K
|
180K
$110K
|
|
|
Jan 26, 2024
Q4 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-1.24M- 7.2% |
$531K - $976K
|
15.9M
$9.71M
|